Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 5 records, 1 pages
Search For: drug eluting balloon for coronary artery disease
Global Drug Eluting Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2024-2030
24 Feb 2024
Medical Devices & Consumables
Drug Eluting Balloon for Coronary Artery Disease
The global Drug Eluting Balloon for Coronary Artery Disease market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Drug Eluting Balloon for Coronary Artery Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
05 Jan 2024
Medical Devices & Consumables
Drug Eluting Balloon for Coronary Artery Disease
According to our (Global Info Research) latest study, the global Drug Eluting Balloon for Coronary Artery Disease market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.
USD3480.00
Add To Cart
Global Drug Eluting Balloon for Coronary Artery Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
06 Feb 2023
Medical Devices & Consumables
Drug Eluting Balloon for Coronary Artery Disease
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
USD3480.00
Add To Cart
Global Drug Eluting Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2023-2029
03 Feb 2023
Medical Devices & Consumables
Drug Eluting Balloon for Coronary Artery Disease
The global Drug Eluting Balloon for Coronary Artery Disease market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Drug Eluting Balloon for Coronary Artery Disease Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
09 Sep 2022
Medical Devices & Consumables
drug eluting balloon for coronary artery disease
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: drug eluting balloon for coronary artery disease
Total: 5 records, 1 pages
The global Drug Eluting Balloon for Coronary Artery Disease market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Drug Eluting Balloon for Coronary Artery Disease market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.
USD3480.00
Add To Cart
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
USD3480.00
Add To Cart
The global Drug Eluting Balloon for Coronary Artery Disease market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>